| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Gemcitabine | CTRPv2 | pan-cancer | AAC | -0.11 | 0.003 |
| mRNA | tandutinib | CTRPv2 | pan-cancer | AAC | -0.12 | 0.003 |
| mRNA | PF-3758309 | CTRPv2 | pan-cancer | AAC | -0.15 | 0.003 |
| mRNA | Irinotecan | gCSI | pan-cancer | AAC | -0.16 | 0.003 |
| mRNA | ruxolitinib | GDSC1000 | pan-cancer | AAC | 0.1 | 0.003 |
| mRNA | Erlotinib | gCSI | pan-cancer | AAC | 0.17 | 0.003 |
| mRNA | Ki8751 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.003 |
| mRNA | SB52334 | GDSC1000 | pan-cancer | AAC | -0.1 | 0.003 |
| mRNA | decitabine | CTRPv2 | pan-cancer | AAC | -0.087 | 0.003 |
| mRNA | chlorambucil | CTRPv2 | pan-cancer | AAC | -0.099 | 0.004 |